Exchange Traded Concepts’s Structure Therapeutics GPCR Stock Holding History

Exchange Traded Concepts’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22M	Sell	25,378 -603	-2%	-$41.3K	0.01%	745
2025 Q4	$1.81M	Sell	25,981 -32,241	-55%	-$1.32M	0.01%	615
2025 Q3	$1.63M	Sell	58,222 -3,510	-6%	-$69.9K	0.01%	621
2025 Q2	$1.28M	Buy	61,732 +22,809	+59%	+$502K	0.02%	593
2025 Q1	$674K	Sell	38,923 -1,512	-4%	-$37K	0.01%	733
2024 Q4	$1.1M	Sell	40,435 -666	-2%	-$23.6K	0.02%	527
2024 Q3	$1.8M	Buy	41,101 +27,019	+192%	+$1.04M	0.04%	357
2024 Q2	$553K	Buy	+14,082	New	+$578K	0.01%	677

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Exchange Traded Concepts's GPCR Position: Q1 2026 in Review

Exchange Traded Concepts reduced its Structure Therapeutics (GPCR) stake by 2.3% in Q1 2026, selling an estimated $41.3K and leaving 25,378 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #745.

Exchange Traded Concepts first reported a position in GPCR in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.81M in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

Exchange Traded Concepts held 25,378 shares of Structure Therapeutics worth $1.22M as of Q1 2026.
Exchange Traded Concepts sold 603 Structure Therapeutics shares in Q1 2026, an estimated $41.3K.
Structure Therapeutics made up 0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #745 holding.
Exchange Traded Concepts first reported a position in Structure Therapeutics in Q2 2024 and has held it in 8 quarters since.
Exchange Traded Concepts's Structure Therapeutics position peaked at $1.81M in Q4 2025.
196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.